Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
05 2020
Historique:
received: 02 09 2019
revised: 18 11 2019
accepted: 20 11 2019
pubmed: 12 2 2020
medline: 16 2 2021
entrez: 12 2 2020
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease is the most prevalent liver disease worldwide, affecting 20%-25% of the adult population. In 25% of patients, nonalcoholic fatty liver disease progresses to nonalcoholic steatohepatitis (NASH), which increases the risk for the development of cirrhosis, liver failure, and hepatocellular carcinoma. In patients with NASH, liver fibrosis is the main determinant of mortality. Here, we review how interactions between different liver cells culminate in fibrosis development in NASH, focusing on triggers and consequences of hepatocyte-macrophage-hepatic stellate cell (HSC) crosstalk. We discuss pathways through which stressed and dead hepatocytes instigate the profibrogenic crosstalk with HSC and macrophages, including the reactivation of developmental pathways such as TAZ, Notch, and hedgehog; how clearance of dead cells in NASH via efferocytosis may affect inflammation and fibrogenesis; and insights into HSC and macrophage heterogeneity revealed by single-cell RNA sequencing. Finally, we summarize options to therapeutically interrupt this profibrogenic hepatocyte-macrophage-HSC network in NASH.

Identifiants

pubmed: 32044315
pii: S0016-5085(20)30169-4
doi: 10.1053/j.gastro.2019.11.311
pmc: PMC7682538
mid: NIHMS1568905
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1913-1928

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK116620
Pays : United States

Informations de copyright

Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Références

Nat Rev Gastroenterol Hepatol. 2018 Dec;15(12):738-752
pubmed: 30250076
Immunol Rev. 2017 Mar;276(1):165-177
pubmed: 28258690
Gastroenterology. 2008 Feb;134(2):568-76
pubmed: 18082745
BMC Gastroenterol. 2019 Feb 11;19(1):27
pubmed: 30744560
Nat Med. 2011 Jul 31;17(8):961-7
pubmed: 21804540
Gastroenterology. 2018 Aug;155(2):307-310.e2
pubmed: 29660324
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4477-82
pubmed: 15070743
Mol Immunol. 2019 Mar;107:29-40
pubmed: 30639476
Boll Soc Ital Biol Sper. 1988 Sep;64(9):801-7
pubmed: 2854476
Cell. 2014 Jun 5;157(6):1324-1338
pubmed: 24906150
Lab Invest. 2015 Oct;95(10):1130-44
pubmed: 26214582
Hepatology. 2016 Apr;63(4):1170-83
pubmed: 26663021
J Clin Invest. 2018 Jun 1;128(6):2436-2451
pubmed: 29558367
Nat Commun. 2013;4:2823
pubmed: 24264436
Oncogene. 2019 Mar;38(12):2206-2222
pubmed: 30470823
J Hepatol. 2017 Oct;67(4):809-817
pubmed: 28645738
Annu Rev Physiol. 2018 Feb 10;80:353-387
pubmed: 29433414
Cell. 2019 May 2;177(4):881-895.e17
pubmed: 31051106
Trends Cell Biol. 2018 Jul;28(7):560-573
pubmed: 29665979
IUBMB Life. 2019 Sep;71(9):1382-1390
pubmed: 31087761
Gastroenterology. 2006 Feb;130(2):435-52
pubmed: 16472598
Gastroenterology. 2012 Apr;142(4):918-927.e6
pubmed: 22178212
J Biol Chem. 2009 Feb 27;284(9):5637-44
pubmed: 19119140
J Clin Invest. 2018 Jun 1;128(6):2419-2435
pubmed: 29558368
PLoS One. 2016 Jun 27;11(6):e0158156
pubmed: 27347680
Nature. 2011 May 26;473(7348):528-31
pubmed: 21532591
J Clin Invest. 2003 Nov;112(9):1383-94
pubmed: 14597764
Hepatology. 2008 Sep;48(3):920-30
pubmed: 18613151
Hepatology. 2009 Jul;50(1):261-74
pubmed: 19554540
Gastroenterology. 2012 Sep;143(3):765-776.e3
pubmed: 22687286
Gastroenterology. 2003 Jan;124(1):97-104
pubmed: 12512034
J Hepatol. 2019 Oct;71(4):823-833
pubmed: 31300231
Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):213-22
pubmed: 21476916
Hepatology. 2020 Jul;72(1):72-87
pubmed: 31610032
Hepatology. 2007 Oct;46(4):1081-90
pubmed: 17654743
J Lipid Res. 2013 May;54(5):1326-34
pubmed: 23417738
Hepatology. 2018 May;67(5):1754-1767
pubmed: 28833331
Nat Med. 2013 Aug;19(8):1054-60
pubmed: 23832089
Biochim Biophys Acta. 2013 Jul;1832(7):1061-9
pubmed: 23022478
J Clin Invest. 1998 Aug 1;102(3):538-49
pubmed: 9691091
Gut. 2017 Jun;66(6):1123-1137
pubmed: 26818617
Cells. 2019 May 24;8(5):
pubmed: 31137713
JHEP Rep. 2019 Feb 23;1(1):30-43
pubmed: 32149275
Hepatol Commun. 2019 Jul 23;3(9):1221-1234
pubmed: 31497743
Diabetes. 2010 Feb;59(2):347-57
pubmed: 19934001
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
Gastroenterology. 2010 Jul;139(1):323-34.e7
pubmed: 20347818
Semin Liver Dis. 2019 May;39(2):235-248
pubmed: 30912096
Gut. 2012 Sep;61(9):1323-9
pubmed: 22427237
Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):397-411
pubmed: 29748586
Sci Rep. 2019 Feb 20;9(1):2324
pubmed: 30787418
Hepatology. 2010 Aug;52(2):774-88
pubmed: 20683968
Physiol Rev. 2008 Jan;88(1):125-72
pubmed: 18195085
Cell Metab. 2016 Dec 13;24(6):848-862
pubmed: 28068223
Nat Commun. 2016 Aug 18;7:12502
pubmed: 27535340
J Gastroenterol. 2018 Dec;53(12):1285-1291
pubmed: 29680867
Front Endocrinol (Lausanne). 2018 Oct 15;9:588
pubmed: 30374329
Gastroenterology. 2015 Aug;149(2):389-97.e10
pubmed: 25935633
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
Gastroenterology. 2006 May;130(6):1564-72
pubmed: 16697719
Hepatology. 2010 Feb;51(2):511-22
pubmed: 20054868
Cancer Cell. 2014 Oct 13;26(4):549-64
pubmed: 25314080
Hepatology. 2000 Jul;32(1):91-6
pubmed: 10869294
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659437
Cell Rep. 2019 Nov 12;29(7):1832-1847.e8
pubmed: 31722201
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411
pubmed: 28487545
Gastroenterology. 2007 May;132(5):1937-46
pubmed: 17484886
Hepatol Res. 2018 Apr;48(5):397-407
pubmed: 29243365
Cell Cycle. 2013 Feb 1;12(3):381-2
pubmed: 23324345
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25
pubmed: 27273168
Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):527-539
pubmed: 28676707
Nanomedicine (Lond). 2016 Oct;11(20):2663-2677
pubmed: 27628057
EMBO Mol Med. 2014 Jun 24;6(8):1062-74
pubmed: 24963148
J Exp Med. 2015 Apr 6;212(4):447-56
pubmed: 25800956
Gastroenterology. 2015 Mar;148(3):547-55
pubmed: 25461851
J Hepatol. 2015 Sep;63(3):679-88
pubmed: 25908270
Gastroenterology. 2017 Dec;153(6):1568-1580.e10
pubmed: 28859855
Front Immunol. 2018 Jan 25;9:44
pubmed: 29422896
Semin Liver Dis. 2019 Jul;39(3):315-333
pubmed: 31226725
Hepatology. 2020 May;71(5):1813-1830
pubmed: 31505040
J Clin Invest. 2005 Nov;115(11):3072-82
pubmed: 16276416
Exp Mol Pathol. 2015 Aug;99(1):155-62
pubmed: 26112094
J Hepatol. 2014 Oct;61(4):883-90
pubmed: 24845607
Hepatology. 2007 Jun;45(6):1366-74
pubmed: 17476695
Gastroenterology. 2012 Jan;142(1):130-139.e4
pubmed: 21945831
Am J Physiol Gastrointest Liver Physiol. 2001 Jul;281(1):G200-7
pubmed: 11408273
Hepatology. 2014 Feb;59(2):471-82
pubmed: 23913408
Cell Mol Gastroenterol Hepatol. 2019;7(2):447-456
pubmed: 30739869
Gastroenterology. 2018 Aug;155(2):443-457.e17
pubmed: 29733831
Gut. 2008 Jan;57(1):84-90
pubmed: 17715267
Dev Cell. 2016 Aug 22;38(4):333-44
pubmed: 27554855
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159
pubmed: 30482910
Hepatology. 2006 Mar;43(3):435-43
pubmed: 16496318
Nat Genet. 2014 Apr;46(4):352-6
pubmed: 24531328
J Hepatol. 2012;56 Suppl 1:S66-74
pubmed: 22300467
Best Pract Res Clin Gastroenterol. 2017 Apr;31(2):129-141
pubmed: 28624101
J Hepatol. 2010 Oct;53(4):719-23
pubmed: 20624660
Dig Dis Sci. 2014 Jun;59(6):1197-206
pubmed: 24795036
Nat Med. 2019 Apr;25(4):641-655
pubmed: 30936549
Nat Med. 2007 Nov;13(11):1324-32
pubmed: 17952090
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3186-95
pubmed: 23100531
Obes Surg. 2007 Apr;17(4):486-92
pubmed: 17608261
J Cell Sci. 2004 Jul 1;117(Pt 15):3165-74
pubmed: 15226394
Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):223-31
pubmed: 21476917
Gastroenterology. 2012 Oct;143(4):1073-83.e22
pubmed: 22750464
Semin Liver Dis. 2017 Feb;37(1):1-10
pubmed: 28201843
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8681-5
pubmed: 3909149
Hepatol Commun. 2019 Jun 06;3(8):1098-1112
pubmed: 31388630
J Hepatol. 2009 Aug;51(2):371-9
pubmed: 19501928
Nat Genet. 2008 Dec;40(12):1461-5
pubmed: 18820647
Cell Metab. 2011 Jul 6;14(1):21-32
pubmed: 21723501
Science. 1999 Apr 30;284(5415):770-6
pubmed: 10221902
Semin Liver Dis. 2015 May;35(2):97-106
pubmed: 25974896
Hepatology. 2017 Mar;65(3):969-982
pubmed: 28035785
Liver Int. 2013 Aug;33(7):1056-61
pubmed: 23617943
Immunity. 2019 May 21;50(5):1149-1162
pubmed: 31117011
J Clin Invest. 2005 Jan;115(1):56-65
pubmed: 15630444
Gastroenterology. 2014 Dec;147(6):1378-92
pubmed: 25173753
N Engl J Med. 2017 Nov 23;377(21):2063-2072
pubmed: 29166236
Science. 2009 Nov 27;326(5957):1216-9
pubmed: 19965464
J Immunol. 2018 Nov 15;201(10):3017-3035
pubmed: 30322964
Hepatology. 2007 Jun;45(6):1343-6
pubmed: 17538963
Gastroenterology. 2012 Jan;142(1):152-164.e10
pubmed: 21995947
Gastroenterology. 2009 Jul;137(1):297-308, 308.e1-4
pubmed: 19208365
Nature. 2018 Aug;560(7718):291-292
pubmed: 30108348
J Pathol. 2011 Jul;224(3):401-10
pubmed: 21547909
J Hepatol. 2003 Apr;38(4):511-7
pubmed: 12663245
Anesthesiology. 1986 Mar;64(3):364-6
pubmed: 3954132
Am J Physiol Heart Circ Physiol. 2016 May 1;310(9):H1064-70
pubmed: 26921440
EMBO Mol Med. 2019 Feb;11(2):
pubmed: 30591521
Nature. 2015 Feb 26;518(7540):547-51
pubmed: 25470051
Annu Rev Pathol. 2017 Jan 24;12:153-186
pubmed: 27959632
Hepatology. 2011 Jan;53(1):106-15
pubmed: 20967826
Lab Invest. 2003 May;83(5):655-63
pubmed: 12746475
Surg Obes Relat Dis. 2019 Mar;15(3):502-511
pubmed: 30683512
Mol Cell. 2019 Aug 8;75(3):644-660.e5
pubmed: 31398325
Cell Metab. 2006 Sep;4(3):185-98
pubmed: 16950136
Cell. 2018 Sep 20;175(1):133-145.e15
pubmed: 30220454
Nat Med. 2019 Oct;25(10):1560-1565
pubmed: 31591593
Nat Med. 2013 Dec;19(12):1617-24
pubmed: 24216753
Hepatology. 2011 Jun;53(6):2003-15
pubmed: 21433043
Diabetes Metab. 2019 Jun;45(3):213-223
pubmed: 30708071
Nat Commun. 2016 Jan 08;7:10255
pubmed: 26743335
Hepatology. 2013 Oct;58(4):1461-73
pubmed: 23553591
Hepatology. 2018 Apr;67(4):1270-1283
pubmed: 28940700
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
Gastroenterology. 2014 Oct;147(4):765-783.e4
pubmed: 25046161
J Lipid Res. 2017 Jun;58(6):1067-1079
pubmed: 28404639
Hepatology. 2009 Jun;49(6):1859-67
pubmed: 19378345
Gastroenterology. 2003 Aug;125(2):437-43
pubmed: 12891546
Hepatology. 2015 Mar;61(3):1066-79
pubmed: 25066777
Diabetes. 2013 Dec;62(12):4052-62
pubmed: 23990360
Science. 2019 Mar 1;363(6430):989-993
pubmed: 30819964
Hepatology. 2014 Jan;59(1):49-57
pubmed: 23929603
J Hepatol. 2018 Mar;68(3):550-562
pubmed: 29107151
Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1310-21
pubmed: 22442158
J Hepatol. 2006 Jul;45(1):60-71
pubmed: 16515819
Ann Hepatol. 2006 Jan-Mar;5(1):30-3
pubmed: 16531962
Endocrinol Metab (Seoul). 2018 Mar;33(1):33-43
pubmed: 29589386
Obes Surg. 2006 Mar;16(3):270-8
pubmed: 16545157
Sci Transl Med. 2018 Nov 21;10(468):
pubmed: 30463916
J Biol Chem. 2005 May 27;280(21):20589-95
pubmed: 15788402
Hepatology. 2015 Jan;61(1):98-107
pubmed: 24849310
Hepatology. 2015 Jan;61(1):15-7
pubmed: 24975580
Nat Rev Endocrinol. 2019 May;15(5):261-273
pubmed: 30670819

Auteurs

Robert F Schwabe (RF)

Department of Medicine, Columbia University, New York, New York; Institute of Human Nutrition, Columbia University, New York, New York. Electronic address: rfs2102@cumc.columbia.edu.

Ira Tabas (I)

Department of Medicine, Columbia University, New York, New York; Institute of Human Nutrition, Columbia University, New York, New York; Department of Physiology and Cellular Biophysics, Columbia University, New York, New York.

Utpal B Pajvani (UB)

Department of Medicine, Columbia University, New York, New York; Institute of Human Nutrition, Columbia University, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH